Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 20:35:24 - browse：58383

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： FDA investigates CAR

focus

Wikipedia

WSS

Problems with a popular proposal to regulate AI in health care

Top private equity targets in 2023: cardiology, clinical trials, lasers

Takeda, Janssen join wearable maker to measure scratching

The EPA's new lead rule: How one expert crunched the numbers

As biotech industry slumps, bioscience job market is upside down

A protest over insulin prices is seen as a fight for life

focus

Wikipedia

leisure time

Hollywood unions extend contract negotiations for actors

Global cancer cases to surge 77% by 2050, WHO report says

Apple is now the first public company to be valued at $3 trillion

Despite FDA concern, risk that CAR

What does generative AI mean for health care? We asked experts

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Malaria cases in Florida and Texas: Here’s what you need to know

Why Novartis is going to walk from its acquisition of MorphoSys

Bright Health sells Medicare Advantage business to Molina

ReNAgade cuts staff seven months after raising $300 million

explore

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Unique patient identifier: Experts argue the benefits, pitfalls

What don’t we know about an Alzheimer’s drug side effect?

ReNAgade cuts staff seven months after raising $300 million

Global cancer cases to surge 77% by 2050, WHO report says

focus

Wikipedia

focus

Wikipedia